4
Changes in Ownership
Twist Bioscience Corp Filed Acc 0001214659-25-014856
Chief Financial Officer sold 5,517 shares at an average $31.96 ($176,315)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Laponis Adam · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-08 | Sale : show line 1 in the form 10b5-1 | −3,000 | $31.15 | $93,450 | 94,042 | D |
| 2025-10-09 | Sale : show line 2 in the form 10b5-1 | −2,517 | $32.92 | $82,865 | 91,525 | D |
| Open-market sales · 5,517 sh · avg $31.96 · $176,315 | ||||||
Loading xslF345X05/marketforms-71020.xml…